NCT00162656View on ClinicalTrials.gov

Treatment of Mature B-cell Lymphoma/Leukaemia

PHASE3CompletedINTERVENTIONAL
Enrollment

848

Participants

Timeline

Start Date

May 31, 1996

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2011

Conditions
B-Cell Lymphoma
Interventions
DRUG

half cyclophosphamide

DRUG

without COPADM3

DRUG

mini CYVE, without 3 maintenance courses

DRUG

LMB B

DRUG

LMB C

Trial Locations (3)

94800

Institut Gustave Roussy, Villejuif

Unknown

Morgan Stanley Childrens Hospital of New York Presbyterian, New York

Sheffield Children's Hospital, Sheffield

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT00162656 - Treatment of Mature B-cell Lymphoma/Leukaemia | Biotech Hunter | Biotech Hunter